fbpx

Clinical Trials

Randomized Clinical Trial

The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib

Value-based Oncology Leader Improving Access to Cutting-Edge Therapies CERRITOS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI), today announces the …

Read More
Medical Provider Examines Pelvic Bone

On the Path to Treating Myelofibrosis

Myelofibrosis (MF) is a rare condition that occurs in the bone marrow, disrupting the body’s normal production of red and white blood cells. This type of cancer, which causes scarring in the bone marrow, can develop on …

Read More
clinical trials at TOI

Clinical Trials at ICRI: August Round-Up

Deciding to participate in a clinical trial is a personal decision that can potentially have a profound beneficial impact on a patient’s cancer journey. Although many patients may be interested in …

Read More
Woman in lab holds testing materials

Understanding Clinical Trials

Video: Tarek Dessouky, MD, MBA, MPH, Executive Director, Innovative Clinical Research Institute (ICRI) talks about the research arm of The Oncology Institute (TOI) and discusses …

Read More

© 2022 The Oncology Institute of Hope and Innovation. All rights reserved.

Skip to content